Aeglea BioTherapeutics, Inc.
Methods For Production Of Human Recombinant Arginase 1 And Uses Thereof

Last updated:

Abstract:

Described are methods for producing recombinant Arginase, such as PEGylated, cobalt-substituted recombinant human Arginase 1. Also described are pharmaceutical compositions comprising such recombinant Arginase, as well as methods of treatment and uses of such recombinant Arginase.

Status:
Application
Type:

Utility

Filling date:

28 Aug 2020

Issue date:

24 Jun 2021